Multiple Myeloma Partnership with Juno Therapeutics for Developing CAR T Cell Immunotherapy Against Multiple Novel Targets
EMERYVILLE, Calif. & NEW YORK & SEATTLE, Aug 4th, 2016 – Eureka Therapeutics, Inc. and Memorial Sloan Kettering Cancer Center(MSK) announced today an exclusive license agreement